Ge healthcare receives fda clearance of allia igs pulse - the next generation of image-guided systems designed for cardiac imaging excellence

Chicago--(business wire)--today, ge healthcare (nasdaq: gehc) announced us fda 510(k) clearance of allia igs pulse - the latest addition to the company's image guided system (igs) offerings. allia igs pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size. in modern healthcare today, cardiovascular disease (cvd) continues to grow in prevalence, with cvds being the leading ca.
GEHC Ratings Summary
GEHC Quant Ranking